Penetration of drugs through skin, a complex rate-controlling membrane

Current Opinion in Colloid and Interface Science

Volumn 17, Issue 3, 2012, Pages 156-165

  Bolzinger, Marie Alexandrine ^a,b   Briançon, Stéphanie ^a,b   Pelletier, Jocelyne ^a,b   Chevalier, Yves ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Nanoparticles; Skin; Skin absorption; Skin penetration; Stratum corneum; Topical drug delivery

Indexed keywords

AREAS OF CONCERNS; COSMETIC PRODUCTS; CRYSTALLINE STATE; HAIR FOLLICLES; IMMUNE SYSTEMS; MICRO-PARTICLES; PENETRATION MECHANISMS; RATE-CONTROLLING; SKIN ABSORPTION; SKIN PENETRATION; SKIN STRUCTURE; STRATUM CORNEUM; TRANSDERMAL; TRANSDERMAL DELIVERY; VACCINATION STRATEGY;

CRYSTALLINE MATERIALS; DRUG DELIVERY; SKIN;

NANOPARTICLES;

COSMETIC; NANOPARTICLE;

DRUG FORMULATION; DRUG PENETRATION; DRUG RESEARCH; DRUG TRANSPORT; ENVIRONMENTAL EXPOSURE; HAIR FOLLICLE; HUMAN; NONHUMAN; PRODUCT SAFETY; REVIEW; RISK ASSESSMENT; SKIN DECONTAMINATION; SKIN PENETRATION; SKIN STRUCTURE; STRATUM CORNEUM;

EID: 84859999642     PISSN: 13590294     EISSN: 18790399     Source Type: Journal    
DOI: 10.1016/j.cocis.2012.02.001     Document Type: Review

References (86)

1. Prausnitz M.R., Langer R. Transdermal drug delivery. Nat Biotechnol 2008, 26:1261-1268.
2. Transdermal drug delivery 1989, Marcel Dekker, New York. J. Hadgraft, R.H. Guy (Eds.).
3. OECD guideline for the testing of chemicals. N° 428 2004.
4. Scientific committee on consumer safety, SCCS Basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients 2010.
5. Elias P.M. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol 1983, 80:44s-49s.
6. Pilgram G.S.K., Engelsma-van Pelt A.M., Bouwstra J.A., Koerten H.K. Electron diffraction provides new information on human stratum corneum lipid organization studied in relation to depth and temperature. J Invest Dermatol 1999, 113:403-409.
7. Bouwstra JA, Gooris GS, Ponec M. Skin lipid organization, composition and barrier function. IFSCC Magazine 2007; 10: 297-307.
8. Barry B.W. Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev 2002, 54:S31-S40.
9. Liu X., Testa B., Fahr A. Lipophilicity and its relationship with passive drug permeation. Pharm Res 2011, 28:962-977.
10. Potts R.O., Guy R.H. Predicting skin permeability. Pharm Res 1992, 9:663-669.
11. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997, 23:3-25.
12. Choi Y.B., Prausnitz M.R. The rule of five for non-oral routes of drug delivery: ophthalmic, inhalation and transdermal. Pharm Res 2011, 28:943-948.
13. Wartewig S., Neubert R.H.H. Pharmaceutical applications of Mid-IR and Raman spectroscopy. Adv Drug Deliv Rev 2005, 57:1144-1147.
14. Mélot M., Pudney P.D.A., Williamson A.M., Caspers P.J., Van Der Pol A., Puppels G.J. Studying the effectiveness of penetration enhancers to deliver retinol through the stratum cornea by in vivo confocal Raman spectroscopy. J Control Release 2009, 138:32-39.
15. Tfayli A., Guillard E., Manfait M., Baillet-Guffroy A. Raman spectroscopy: feasibility of in vivo survey of stratum corneum lipids, effect of natural aging. Eur J Dermatol 2012, 22:36-41.
16. Förster M., Bolzinger M.A., Ach D., Montagnac G., Briançon S. Ingredients tracking of cosmetic formulations in the skin: a confocal Raman microscopy investigation. Pharm Res 2011, 28:858-872.
17. Förster M., Bolzinger M.A., Reynard B., Briançon S. Confocal Raman microspectroscopy of the skin. Eur J Dermatol 2011, 21:851-863.
18. Knorr F., Lademann J., Patzelt A., Sterry W., Blume-Peytavi U., Vogt A. Follicular transport route - research progress and future perspectives. Eur J Pharm Biopharm 2009, 71:173-180.
19. Madison K.C., Swartzendruber D.C., Wertz P.W., Downing D.T. Presence of intact intercellular lipid lamellae in the upper layers of the stratum corneum. J Invest Dermatol 1987, 88:714-718.
20. Bouwstra J.A., Gooris G.S., van der Spek J.A., Bras W. Structural Investigations of human stratum corneum by small angle X-ray scattering. J Invest Dermatol 1991, 97:1005-1012.
21. Bouwstra J.A., Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta Biomembr 2006, 1758:2080-2095.
22. Forslind B. A domain mosaic model of the skin barrier. Acta Derm Venereol 1994, 74:1-6.
23. Swartzendruber D.C., Wertz P.W., Kitko D.J., Madison K.C., Downing D.T. Molecular models of the intercellular lipid lamellae in mammalian stratum corneum. J Invest Dermatol 1989, 92:251-257.
24. Norlén L. Skin barrier structure and function: the single gel phase model. J Invest Dermatol 2001, 117:830-836.
25. Damien F., Boncheva M. The extent of orthorhombic lipid phases in the stratum corneum determines the barrier efficiency of human skin in vivo. J Invest Dermatol 2010, 130:611-614.
26. Boncheva M., Damien F., Normand V. Molecular organization of the lipid matrix in intact stratum corneum using ATR-FTIR spectroscopy. Biochim Biophys Acta 2008, 1778:1344-1355.
27. Bouwstra J.A., Pilgram G.S.K., Ponec M. Does the single gel phase exist in stratum corneum?. J Invest Dermatol 2002, 118:897-898.
28. Norlén L. Reply. J Invest Dermatol 2002, 118:899-901.
29. Norlén L., Plasencia Gil I., Simonsen A., Descouts P. Human stratum corneum lipid organization as observed by atomic force microscopy on Langmuir-Blodgett films. J Struct Biol 2007, 158:386-400.
30. Berthaud F., Boncheva M. Correlation between the properties of the lipid matrix and the degrees of integrity and cohesion in healthy human stratum corneum. Exp Dermatol 2010, 20:255-262.
31. Babita K., Kumar V., Rana V., Jain S., Tiwary A.K. Thermotropic and spectroscopic behavior of skin: relationship with percutaneous permeation enhancement. Curr Drug Deliv 2006, 3:95-113.
32. Duracher L., Blasco L., Jaoued A.A., Vian L., Marti-Mestres G. Irradiation of skin and contrasting effects on absorption of hydrophilic and lipophilic compounds. Photochem Photobiol 2009, 85:1459-1467.
33. Groen D., Poole D.S., Gooris G.S., Bouwstra J.A. Is an orthorhombic lateral packing and a proper lamellar organization important for the skin barrier function?. Biochim Biophys Acta Biomembr 2011, 1808:1529-1537.
34. Williams A.C., Barry B.W. Penetration enhancers. Adv Drug Deliv Rev 2004, 56:603-618.
35. Benson H.A.E. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2005, 2:23-33.
36. van Hal D.A., Jeremiasse E., Junginger H.E., Spies F., Bouwstra J.A. Structure of fully hydrated human stratum corneum: a freeze-fracture electron microscopy study. J Invest Dermatol 1996, 106:89-95.
37. Rodríguez G., Barbosa-Barros L., Rubio L., Cócera M., Díez A., Estelrich J., et al. Conformational changes in stratum corneum lipids by effect of bicellar systems. Langmuir 2009, 25:10595-10603.
38. Diembeck W., Beck H., Benech-Kieffer F., Courtellemont P., Dupuis J., Lovell W., et al. Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. Food Chem Toxicol 1999, 37:191-205.
39. Tregear R.T. Relative penetrability of hair follicles and epidermis. J Physiol 1961, 156:307-313.
40. Illel B., Schaefer H., Wepierre J., Doucet O. Follicles play an important role in percutaneous absorption. J Pharm Sci 1991, 80:424-427.
41. Meidan V.M., Bonnr M.C., Michniak B.B. Transfollicular drug delivery-is it a reality?. Int J Pharm 2005, 306:1-14.
42. Alvarez-Román R., Naik A., Kalia Y.N., Guy R.H., Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release 2004, 99:53-62.
43. Alvarez-Román R., Naik A., Kalia Y.N., Fessi H., Guy R.H. Visualization of skin penetration using confocal laser scanning microscopy. Eur J Pharm Biopharm 2004, 58:301-316.
44. Lademann J., Richter H., Teichmann A., Otberg N., Blume-Peytavi U., Luengo J., et al. Nanoparticles-an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 2007, 66:159-164.
45. Lauer A.C., Ramachandran C., Lieb L.M., Niemec S., Weiner N.D. Targeted delivery to the pilosebaceous unit via liposomes. Adv Drug Deliv Rev 1996, 18:311-324.
46. Mitragotri S. Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J Control Release 2003, 86:69-92.
47. Otberg N., Richter H., Schaefer H., Blume-Peytavi U., Sterry W., Lademann J. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 2004, 122:14-19.
48. Blume-Peytavi U., Vogt A. Human hair follicle: reservoir function and selective targeting. Br J Dermatol 2011, 165:13-17. (Suppl).
49. Lademann J., Richter H., Schaefer U.F., Blume-Peytavi U., Teichmann A., Otberg N., et al. Hair follicles-a long-term reservoir for drug delivery. Skin Pharmacol Physiol 2006, 19:232-236.
50. Teichmann A., Otberg N., Jacobi U., Sterry W., Lademann J. Follicular penetration: development of a method to block the follicles selectively against the penetration of topically applied substances. Skin Pharmacol Physiol 2006, 19:216-223.
51. Trauer S., Lademann J., Knorr F., Richter H., Liebsch M., Rozycki C., et al. Development of an in vitro modified skin absorption test for the investigation of the follicular penetration pathway of caffeine. Skin Pharmacol Physiol 2010, 23:320-327.
52. Trauer S., Patzelt A., Otberg N., Knorr F., Rozycki C., Balizs G., et al. Permeation of topically applied caffeine through human skin-a comparison of in vivo and in vitro data. Br J Clin Pharmacol 2009, 68:181-186.
53. Rolland P., Bolzinger M.A., Cruz C., Briançon S., Josse D. Human scalp permeability to the chemical warfare agent VX. Toxicol In Vitro 2011, 25:1974-1980.
54. Bolzinger M.A., Briançon S., Pelletier J., Fessi H., Chevalier Y. Percutaneous release of caffeine from microemulsion, emulsion and gel dosage forms. Eur J Pharm Biopharm 2008, 68:446-451.
55. Jacobi U., Kaiser M., Toll R., Mangelsdorf S., Audring H., Otberg N., et al. Porcine ear skin an: in vitro model for human skin. Skin Res Technol 2007, 13:19-24.
56. Lademann J., Patzelt A., Richter H., Schanzer S., Sterry W., Filbry A., et al. Comparison of two in vitro models for the analysis of follicular penetration and its prevention by barrier emulsions. Eur J Pharm Biopharm 2009, 72:600-604.
57. Vallet V., Cruz C., Licausi J., Bazire A., Lallement G., Boudry I. Percutaneous penetration and distribution of VX using in vitro pig or human excised skin validation of demeton-s-methyl as adequate simulant for VX skin permeation investigations. Toxicology 2008, 246:73-82.
58. Microspheres, microcapsules, & liposomes 1999, Citus books, London. R. Arshady (Ed.).
59. Bolzinger M.-A., Briançon S., Chevalier Y. Nanoparticles through the skin: managing conflicting results of inorganic and organic particles in cosmetics and pharmaceutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, 3:463-478.
60. Lombardi Borgia S., Regehly M., Sivaramakrishnan R., Mehnert W., Korting H.C., Danker K., et al. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release 2005, 110:151-163.
61. Cevc G., Vierl U. Nanotechnology and the transdermal route. A state of the art review and critical appraisal. J Control Release 2010, 141:277-299.
62. Roberts M.S., Dancik Y., Prow T.W., Thorling C.A., Lin L.L., Grice J.E., et al. Non-invasive imaging of skin physiology and percutaneous penetration using fluorescence spectral and lifetime imaging with multiphoton and confocal microscopy. Eur J Pharm Biopharm 2011, 77:469-488.
63. Patzelt A., Richter H., Knorr F., Schäfer U., Lehr C.M., Dähne L., et al. Selective follicular targeting by modification of the particle sizes. J Control Release 2011, 150:45-48.
64. Moore K.A., Lemischka I.R. Stem cells and their niches. Science 2006, 311:1880-1885.
65. Toll R., Jacobi U., Richter H., Lademann J., Schaefer H., Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 2004, 123:168-176.
66. Combadière B., Mahé B. Particle-based vaccines for transcutaneous vaccination. Comp Immunol Microbiol Infect Dis 2008, 31:293-315.
67. Reddy S.T., Swartz M.A., Hubbell J.A. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol 2006, 27:573-579.
68. Mahé B., Vogt A., Liard C., Duffy D., Abadie V., Bonduelle O., et al. Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J Invest Dermatol 2009, 129:1156-1164.
69. Lee P.W., Hsu S.H., Tsai J.S., Chen F.R., Huang P.J., Ke C.J., et al. Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking. Biomaterials 2010, 31:2425-2434.
70. Vogt A., Combadière B., Hadam S., Stieler K.M., Lademann J., Schaefer H., et al. 40nm, but not 750 or 1,500nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol 2006, 126:1316-1322.
71. Manolova V., Flace A., Bauer M., Schwarz K., Saudan P., Bachmann M.F. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008, 38:1404-1413.
72. Rolland A., Wagner N., Chatelus A., Shroot B., Schaefer H. Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm Res 1993, 10:1738-1744.
73. Nohynek G.J., Dufour E.K., Roberts M.S. Nanotechnology, cosmetics and the skin: is there a health risk?. Skin Pharmacol Physiol 2008, 21:136-149.
74. Mavon A., Miquel C., Lejeune O., Payre B., Moretto P. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol 2007, 20:10-20.
75. Monteiro-Riviere N.A., Riviere J.E. Interaction of nanomaterials with skin: aspects of absorption and biodistribution. Nanotoxicology 2009, 3:188-193.
76. Monteiro-Riviere N.A., Baroli B. Nanomaterial penetration. Target Organ Toxicology Series. 2010, 22:333-346. Informa Healthcare, New York. N.A. Monteiro-Riviere (Ed.).
77. Ohulchanskyy T.Y., Roy I., Yong K.-T., Pudavar H.E., Prasad P.N. High-resolution light microscopy using luminescent nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010, 2:162-175.
78. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 2006, 91:159-165.
79. Rouse J.G., Yang J., Ryman-Rasmussen J.P., Barron A.R., Monteiro-Riviere N.A. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett 2007, 7:155-160.
80. Baroli B., Ennas M.G., Loffredo F., Isola M., Pinna R., López-Quintela M.A. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol 2007, 127:1701-1712.
81. Mortensen L.J., Oberdörster G., Pentland A.P., DeLouise L.A. In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett 2008, 8:2779-2787.
82. Sonavane G., Tomoda K., Sano A., Ohshima H., Terada H., Makino K. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids Surf B Biointerfaces 2008, 65:1-10.
83. Filon Larese F., D'Agostin F., Crosera M., Adami G., Renzi N., Bovenzi M., et al. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 2009, 255:33-37.
84. Zhang L.W., Yu W.W., Colvin V.L., Monteiro-Riviere N.A. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol Appl Pharmacol 2008, 228:200-211.
85. Graf C., Meinke M., Gao Q., Hadam S., Raabe J., Sterry W., et al. Qualitative detection of single submicron and nanoparticles in human skin by scanning transmission X-ray microscopy. J Biomed Opt 2009, 14:021015.
86. Lee H.A., Imran M., Monteiro-Riviere N.A., Colvin V.L., Yu W.W., Riviere J.E. Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction. Nano Lett 2007, 7:2865-2870.